Non-Metastatic Esophageal Adenocarcinoma: Circulating Tumor Cells in the Course of Multimodal Tumor Treatment
Background: Isolation of circulating tumor cells (CTC) holds the promise to improve response-prediction and personalization of cancer treatment. In this study, we test a filtration device for CTC isolation in patients with non-metastatic esophageal adenocarcinoma (EAC) within recent multimodal treat...
Main Authors: | Jasmina Kuvendjiska, Peter Bronsert, Verena Martini, Sven Lang, Martha B. Pitman, Jens Hoeppner, Birte Kulemann |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-03-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/11/3/397 |
Similar Items
-
Pattern of Recurrence and Patient Survival after Perioperative Chemotherapy with 5-FU, Leucovorin, Oxaliplatin and Docetaxel (FLOT) for Locally Advanced Esophagogastric Adenocarcinoma in Patients Treated Outside Clinical Trials
by: Torben Glatz, et al.
Published: (2020-08-01) -
Circulating Tumor Cells in Pancreatic Cancer: Current Perspectives
by: Verena Martini, et al.
Published: (2019-10-01) -
Pre-treatment tumor-infiltrating T cells influence response to neoadjuvant chemoradiotherapy in esophageal adenocarcinoma
by: R.S.A. Goedegebuure, et al.
Published: (2021-01-01) -
Circulating Epithelial Cells in Patients with Intraductal Papillary Mucinous Neoplasm of the Pancreas
by: Jasmina Kuvendjiska, et al.
Published: (2023-07-01) -
Clinical outcome of elderly patients (≥ 70 years) with esophageal cancer undergoing definitive or neoadjuvant radio(chemo)therapy: a retrospective single center analysis
by: Franziska Walter, et al.
Published: (2018-05-01)